HomeSLNO • NASDAQ
add
Soleno Therapeutics Inc
Previous close
$63.85
Day range
$43.80 - $49.92
Year range
$41.58 - $90.32
Market cap
2.48B USD
Avg Volume
1.64M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 32.66M | — |
Operating expense | 37.38M | 60.93% |
Net income | -4.71M | 78.46% |
Net profit margin | -14.42 | — |
Earnings per share | — | — |
EBITDA | -4.92M | 78.35% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 286.84M | 7.79% |
Total assets | 332.31M | 9.26% |
Total liabilities | 92.17M | 294.31% |
Total equity | 240.14M | — |
Shares outstanding | 53.15M | — |
Price to book | 13.41 | — |
Return on assets | -4.17% | — |
Return on capital | -4.69% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -4.71M | 78.46% |
Cash from operations | -12.61M | 28.57% |
Cash from investing | -7.92M | 93.45% |
Cash from financing | 15.69M | -89.73% |
Net change in cash | -4.83M | -134.10% |
Free cash flow | 100.00K | 100.91% |
About
Founded
1999
Headquarters
Website
Employees
133
